Home > Insider Trading > Filing (0001437749-23-017608)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1401667	Puma Biotechnology Inc.	PBYI	Pharmaceutical Preparations (2834)	770683487

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1716328	M Brian Stuglik	C/O Puma Biotechnolgy, Inc. 10880 Wilshire Boulevard, Suite 2150 Los Angeles CA 90024		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-06-13	9,900	$3.46	31,958	No	4	S	Direct
Common Stock	Acquisiton	2023-06-13	27,000	$0.00	58,958	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	A	Direct

Footnotes

Adoption date of referenced 10b5-1(c) sell to cover program is: 12-15-2022.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.43 to $3.48, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.